The effects of modified alternate-day fasting diet on weight loss and CAD risk factors in overweight and obese women

Samira Eshghinia, Fatemeh Mohammadzadeh, Samira Eshghinia, Fatemeh Mohammadzadeh

Abstract

Background: Obesity is a worldwide health problem with increasing prevalence. Decrease in energy intake has been shown to lower the risk of coronary artery disease in obese subjects. The common form of dietary restriction is daily calorie restriction (CR). Another form is alternate-day fasting (ADF). This study examined the ability of modified ADF to facilitate weight loss and lower cardiovascular risk factors in overweight and obese women.

Methods: 15 adult subjects completed an 8 weeks trial (2 weeks observed and 6 weeks ADF). All women consumed very low calorie diet on the fast day and usually diet in every other day. Body weight (BW), fat mass and blood pressure (BP) were measured. Fasting blood samples were collected at the first and 57th day of trial for biochemical analysis.

Results: During the course of the trial, BW of the subjects decreased (p < 0/0001) from 84/3 ± 11/44 kg to 78/3 ± 10/18 kg. Waist Circumference decreased from 87/87 ± 9/74 to 82/86 ± 9/68(p < 0/001). Reduction in systolic BP was seen from 114.8 ± 9.16 to 105.13 ± 10.19 mmHg (p < 0/001) and diastolic BP changed from 82.86 ± 10.6 to 74.5 ± 10.8 (P < 0.05). Total cholesterol decreased from 227/73 ± 49/96 to 214/67 ± 43/27, TG from 160/5 ± 46/18 to 143/9 ± 22/77, LDL from 149/46 ± 49/81 to 131/3 ± 50/97, and FBS from 102 ± 14/7 to 96 ± 11/79 mg/dl but were not significant. HDL increased from 42/32 ± 18/01 to 50/58 ± 19/46 and was not significant.

Conclusion: These finding suggest that short time ADF is a viable dietary option to help obese individuals lose weight and decrease some CAD risk factors. More and longer-term studies in human subjects are needed to support this important result.

References

    1. Suzuki K, Simpson KA, Minnion JS, Shillito JC, Bloom SR. The role of gut hormones and the hypothalamus in appetite regulation. Endocrine J. 2010;57(5):359–372. doi: 10.1507/endocrj.K10E-077.
    1. Lau DC. Diabetes and weight management. Prim Care Diabetes. 2010;4(Suppl 1):S24–S30.
    1. Gomes F, Telo DF, Souza HP, Nicolau JC, Halpern A, Serrano CV. Obesity and coronary artery disease: role of vascular inflammation. Arq Bras Cardiol. 2010;94(2):255–261. 273–9, 260–6.
    1. Varady KA, Bhutani S, Church EC, Klempel MC. Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults. Am J Clin Nutr. 2009;90(5):1138–1143. doi: 10.3945/ajcn.2009.28380.
    1. Johnson JB, Laub DR, John S. The effect on health of alternate day calorie restriction: eating less and more than needed on alternate days prolongs life. Med Hypotheses. 2006;67:209–211. doi: 10.1016/j.mehy.2006.01.030.
    1. Reivew of The Dietary Guidelines for Americans. 2010.
    1. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry. 1972;18(6):499–502.
    1. Chaston TB, Dixon JB. Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review. Int J Obes (Lond) 2008;32:619–628. doi: 10.1038/sj.ijo.0803761.
    1. Varady KA, Hellerstein MK. Alternate-day fasting and chronic disease prevention: a review of human and animal trials. Am J Clin Nutr. 2007;86:7–13.
    1. Malik VS, Hu FB. Popular weight-loss diets: from evidence to practice. Nat Clin Pract Cardiovasc Med. 2007;4:34–41. doi: 10.1038/ncpcardio0726.
    1. Das SK, Gilhooly CH, Golden JK, Pittas AG, Fuss PJ, Cheatham RA. et al.Long-term effects of 2 energy-restricted diets differing in glycemic load on dietary adherence, body composition, and metabolism in CALERIE: a 1-y randomized controlled trial. Am J Clin Nutr. 2007;85:1023–1030.
    1. Eshghinia S, Gapparov GM. Effect of short-term modified alternate-day fasting on the lipid metabolism in obese women. Iranian J Diabetes and Obesity. 2011;3(1):1–5.
    1. Johnson JB, Summer W, Cutler RG, Martin B, Hyun DH, Dixit VD, Pearson M. et al.Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med. 2007;42:665–674. doi: 10.1016/j.freeradbiomed.2006.12.005.
    1. Scaglione R, Di Chiara T, Cariello T, Licata G. Visceral obesity and metabolic syndrome: two faces of the same medal? Intern Emerg Med. 2010;5:111–119. doi: 10.1007/s11739-009-0332-6.
    1. Garruti G, Depalo R, Vita MG. Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment. Reprod Biomed Online. 2009;19:552–563. doi: 10.1016/j.rbmo.2009.05.010.
    1. Varady KA, Bhutani S, Klempel MC, Kroeger CM. Comparison of effects of diet versus exercise weight loss regimens on LDL and HDL particle size in obese adults. Lipids Health Dis. 2011;10:119. doi: 10.1186/1476-511X-10-119.
    1. Heilbronn LK, Smith SR, Martin CK, Anton SD, Ravussin E. Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism. Am J Clin Nutr. 2005;81:69–73.
    1. Halberg N, Henriksen M, Soderhamn N, Stallknecht B, Ploug T, Schjerling P. et al.Effect of intermittent fasting and refeeding on insulin action in healthy men. J Appl Physiol. 2005;99:2128–2136. doi: 10.1152/japplphysiol.00683.2005.
    1. Trepanowski JF, Canale RE, Marshall KE, Kabir MM, Bloomer RJ. Impact of caloric and dietary restriction regimens on markers of health and longevity in humans and animals: a summary of available findings. Nutrition Journal. 2011;10:107. doi: 10.1186/1475-2891-10-107.
    1. Heilbronn LK, Civitarese AE, Bogacka I, Smith SR, Hulver M, Ravussin E. Glucose tolerance and skeletal muscle gene expression in response to alternate day fasting. Obes Res. 2005;13:574–581. doi: 10.1038/oby.2005.61.
    1. Ellison RC, Zhang Y, Qureshi MM, Knox S, Arnett DK, Province MA. Lifestyle determinants of high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study. Am Heart J. 2004;147:529–535. doi: 10.1016/j.ahj.2003.10.033.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe